NFG
KPTI icon

Next Financial Group’s Karyopharm Therapeutics KPTI Stock Holding History

Next Financial Group’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7
Closed -$1K – 2451
2019
Q3 		$1K Sell
7
-64
-90% -$8.68K ﹤0.01% 2227
2019
Q2 		$6K Buy
71
+66
+1,320% +$5.3K ﹤0.01% 1837
2019
Q1 		$0 Buy
+5
New +$554 ﹤0.01% 1895
2015
Q4 		– Sell
-7
Closed -$1K – 1874
2015
Q3 		$1K Sell
7
-6
-46% -$1.6K ﹤0.01% 1723
2015
Q2 		$5K Hold
13
– – ﹤0.01% 1481
2015
Q1 		$6K Buy
13
+6
+86% +$2.59K ﹤0.01% 1425
2014
Q4 		$4K Hold
7
– – ﹤0.01% 1584
2014
Q3 		$3K Buy
+7
New +$3.95K ﹤0.01% 2223

Other funds holding KPTI

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Next Financial Group's KPTI Position: Q4 2019 in Review

Next Financial Group sold out of Karyopharm Therapeutics (KPTI) in Q4 2019, closing a stake of 7 shares — an estimated $1K sold.

Next Financial Group first reported a position in KPTI in Q3 2014 and held it in 8 quarters. The position peaked at $6K in Q2 2019. 146 funds tracked by Wall St. Rank hold KPTI as of Q4 2019.

  • Next Financial Group reported no remaining Karyopharm Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Next Financial Group sold 7 Karyopharm Therapeutics shares in Q4 2019, an estimated $1K.
  • Next Financial Group first reported a position in Karyopharm Therapeutics in Q3 2014 and held it in 8 quarters.
  • Next Financial Group's Karyopharm Therapeutics position peaked at $6K in Q2 2019.
  • 146 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2019.

Based on Next Financial Group's 13F filing for Q4 2019, filed 21 Jan 2020.